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Intracerebral Haemorrhage Following Carotid
Endarterectomy
D. A. Russell and M. J. Gough*
Vascular Surgical Unit, The General Infirmary at Leeds, Leeds, UK
Objectives. To determine risk factors for the development of hyperperfusion and intra-cerebral haemorrhage following
carotid endarterectomy and formulate potential protocols for prevention.
Methods. MEDLINE database search of the English language literature (1966–2002) was performed using the words
‘cerebral haemorrhage’, ‘intracranial haemorrhage’ and ‘carotid endarterectomy’. Other articles were cross-referenced by
hand.
Results. There are no data from randomised trials confirming the significance of any single risk factor. The evidence
suggests that the following may have a role: pre-operative hypertension, recent ipsilateral non-haemorrhagic stroke, previous
ischaemic cerebral infarction, surgery for a .90% ipsilateral internal carotid artery (ICA) stenosis, impaired
cerebrovascular reserve, intra-operative haemodynamic or embolic ischaemia, post-operative hypertension, an ipsilateral
increase of $175% in peak middle cerebral artery velocity (MCAV) and/or a $100% increase in pulsatility index.
Conclusions. A critical ICA stenosis with impaired cerebrovascular reserve resulting in maximal intracerebral
vasodilatation and post-operative hyperperfusion (impaired autoregulation) appear to be central to the development of
ICH. Appropriate pre-operative screening and post-operative monitoring in high risk patients might identify those who
would benefit from manipulation of the haemodynamic events that appear to promote ICH.
Key Words: Endarterectomy; Carotid; Intracranial hemorrhage; Cerebral hemorrhage; Post-operative complications.
Introduction
Following publication of the ECST1 and NASCET2
trials carotid endarterectomy (CEA) has been per-
formed with increasing frequency.3 Although these
trials showed that surgery is better than best medical
therapy for stroke prevention in patients with a
symptomatic critical ICA stenosis the combined data
from these, and the VATrial indicate a 30-day stroke or
death rate for CEA of 7.1%.4 Current interest has,
therefore, focused on improving the risk-benefit of
surgery by reducing the number of peri-operative
neurological events.
Strategies by which ischaemic or embolic peri-
operative strokes may be reduced include routine
patching,5,6 intra-operative quality control,7 post-
operative monitoring with transcranial Doppler
(TCD) and intervention for multiple embolic events8
and the performance of CEA under regional rather
than general anaesthesia.9 The latter is currently the
subject of an international randomised trial (The
GALA Trial). There is also evidence suggesting that
the risks associated with CEA are reduced when
surgery is performed by surgeons, or in units, with a
high annual workload.10,11
Despite the promising results of studies that have
assessed the benefit of these techniques in reducing
peri-operative ischaemic strokes the incidence of
haemorrhagic stroke (intracerebral haemorrhage—
ICH) following CEA has remained constant (0.25–
1.8%).12,13 Thus, ICH has assumed increasing signifi-
cance in the pathogenesis of peri-operative neurologi-
cal complications. Furthermore ICH may also occur
following carotid angioplasty and stenting.14–17
A number of risk factors that might increase the risk
of post-CEA ICH have been suggested including
recent cerebral infarction, hypertension, a high-grade
carotid stenosis, impaired cerebrovascular reserve,
post-reperfusion hyperaemia and anticoagulant
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therapy. However, the relative importance of these
remains uncertain. This review will, therefore, exam-
ine the evidence for each and propose protocols for
their identification and management.
Methods
A Medline review of the English language literature
(1966–2002) was performed using the words ‘cerebral
haemorrhage’, ‘intracranial haemorrhage’ and ‘carotid
endarterectomy’. Other articles were cross-referenced
by hand.
Results
Incidence and presentation
Sixteen reports in the English language literature
identified 103 cases of ICH complicating 20,197
CEAs, an overall incidence of 0.51%.7,12,13,18–30 From
these, and nine case reports, detailed information was
available on 86 cases.18–22,24–28,31–39 This data is
summarised in Table 1. The median age of affected
patients was 64 (range: 42–81) years and although
there was a greater proportion of females (41M:43F)
this may reflect publication bias since it was not
evident from the larger series reporting the incidence
of ICH.29,30 The median duration from surgery to
haemorrhage was 4 days (range: intraoperative—25
days) and this was associated with a 67% mortality.
Patients who suffer ICH often have an unremark-
able early post-operative course, are normotensive and
have no neurological deficit.21 The most common
initial symptom is a severe, unilateral frontal or
temporal headache (35%) followed, perhaps after
several days, by seizures associated with an abrupt
rise in systemic blood pressure (17%), the develop-
ment of a neurological deficit (47%) and coma (44%).
Pre-operative risk factors
Cerebral infarction
In 1963 Bruetman reported six cases of ICH following
CEA in patients with a persisting neurological deficit
or EEG evidence of cerebral infarction.21 Subsequently
Wylie reported 5 cases of ICH in nine patients
undergoing operation within one week of stroke,
concluding that following cerebral infarction there
was a critical period during which an increase in
cerebral perfusion pressure could cause serious or
fatal intracranial haemorrhage adjacent to the area of
infarction.24 More recent reports using either compu-
terised tomography (CT) or autopsy confirm that ICH
occurs in areas of pre-operative cerebral infarction.19,
21,22,24,26,31,33
However, ICH also occurs in normal brain par-
enchyma irrespective of the presence or absence of
infarction in other areas of the brain.19,25,36 Similarly, in
an animal model of cerebral ischaemia reversal within
50 minutes resulted in anaemic cerebral infarction
whilst longer periods of ischaemia were associated
with cerebral haemorrhage following reperfusion. The
authors postulated that ischaemia leads to softening
of brain tissue and vessel wall damage with rupture of
the latter, and thus haemorrhage, on resumption of
cerebral blood flow.40
Post-ischaemic damage to the terminal cerebral
vascular net, characterised by perivascular oedema
and clumping of erythrocytes and platelets within
venules and arterioles, was also demonstrated by
Meyer and Denny-Brown.41 Small vessel changes were
particularly noted in the watershed area of ischaemia
and restoration of flow to these damaged vessels
promoted diapedesis and peri-vascular haemorrhage.
Although anticoagulants increased flow rates by
reducing erythrocyte and platelet aggregation, they
resulted in more severe haemorrhage.
Finally, it has also been suggested that peri-
operative embolic events may increase the risk of
cerebral injury. Subsequent fragmentation of emboli or
relaxation of vascular spasm promotes distal move-
Table 1. Prevalence of risk factors in 86 patients presenting with post-CEA intracerebral haemorrhage
Risk factor Present Absent Not documented
Ipsilateral CT infarct or neurological deficit 25/83 (30%) 58/83 (70%) 3/86 (3%)
Ipsilateral carotid stenosis .90% 62/69 (90%) 7/69 (10%) 17/86 (20%)
Contralateral carotid occlusion 16/59 (27%) 43/59 (73%) 27/86 (31%)
Hypertension 40/82 (49%) 41/82 (51%) 4/86 (5%)
Intra-operative BP .160/90 mmHg 15/22 (68%) 7/22 (32%) 64/86 (74%)
Post-operative BP .160/90 mmHg 28/62 (45%) 34/62 (55%) 24/86 (28%)
General anaesthesia 41/44 (93%) 3/44 (7%) 42/86 (49%)
Shunt 28/43 (65%) 15/43 (35%) 43/86 (50%)
Peri-operative anticoagulation 31/58 (53%) 27/58 (47%) 28/86 (33%)
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ment of the embolus and exposure of the previously
ischaemic tissue to the full force of systolic blood
pressure causing haemorrhage from damaged capil-
laries.42
Twenty-seven (31%) of the ICH cases described in
detail had been evaluated by pre-operative cerebral
CT. Of these 11/27 (41%) showed no infarction, 12/27
(44%) ipsilateral infarction, and 4/27 (15%) infarction
contralateral to the hemisphere with a subsequent
ICH.
In summary, although a significant proportion of
patients who develop ICH have a previous cerebral
infarction a similar proportion do not. However, early
CEA following ischaemic stroke may promote ICH
and the timing of CEA in patients referred for surgery
after stroke is controversial. The relative risks to the
patient are those of a further neurological event caused
by an unstable carotid plaque or post-operative ICH.
Unfortunately, there are no guidelines that will
balance the risk of these conflicting hazards although
CT evidence of infarction, a progressive neurological
deficit and reduced conscious level appear to increase
the risk of early CEA for acute stroke.43
Pre-operative cerebral hypoperfusion and impaired
cerebrovascular reserve
Of all the factors proposed as promoting ICH a high-
grade ipsilateral carotid artery stenosis is the most
consistent finding.19,25,27–29,32,44 A .90% stenosis was
present in 90% of patients, 27% of whom also had a
contralateral occlusion. Poor collateralisation was also
noted on cerebral angiography in one of these
studies.27
The mechanism by which a high grade stenosis
imposes a risk of ICH has been explained on the basis
of the ‘normal perfusion pressure breakthrough’
theory described by Spetzler.45 Although this hypoth-
esis explained the occurrence of ICH following
surgery for intracerebral AV malformations it is
equally applicable to patients with severe carotid
disease. In a hemisphere that is chronically ischaemic
secondary to steal by an arteriovenous fistula, auto-
regulation is impaired and the distal arterial network
becomes chronically dilated, thus ensuring maximal
blood flow. When normal flow is re-establishing after
removal or occlusion of the fistula luxury perfusion
occurs due to failure of autoregulation in the dilated
vessels. This leads to cerebral oedema and haemor-
rhage. It has also been suggested that the cerebral
microcirculation is unusually susceptible to injury
after a prolonged period with a reduced perfusion
pressure.32 This theory is supported by the work of
Sundt who demonstrated reduced baseline cerebral
blood flow in five patients who developed ICH
compared to other patients with similar stenoses and
clinical risk factors who made an uneventful recovery
from CEA.46
Patients with pre-operative hypoperfusion and
impaired cerebrovascular reserve can be identified
prior to CEA by TCD measurement of middle cerebral
artery velocity (MCAV) before and after adminis-
tration of a cerebral vasodilator such as inspired CO2
or acetazolamide. Thus Sbarigia et al. were able to
show that patients in whom the MCAV did not
increase after acetazolamide, presumably due to
paralysis of autoregulation and maximal arteriolar
vasodilatation, developed symptomatic cerebral
hyperperfusion after surgery.47
Bilateral carotid disease
Information on the severity of bilateral disease was
available in 60 patients. Of these 28/60 (47%) had a
combined stenosis of .160%. In a further 10 patients
collateralisation from the contralateral side was
described as poor (7), moderate (1), or good (2). Thus
50% of patients developing ICH had either combined
stenoses of .160% or poor collateral flow. Unfortu-
nately, there are no data available on frequency of this
pattern of bilateral carotid disease in patients who do
not develop ICH.
Hypertension
Caplan first proposed hypertension as a cause of ICH,
describing two patients with significant pre-operative
hypertension which became more severe post-opera-
tively and was followed by ICH.33 This suggestion has
been endorsed by several other authors.20–22,30,35
Further evidence of a role for acute hypertension is
available from autopsy studies and post-CEA cerebral
CT scans which show features similar to those of
malignant hypertension (swelling and hyperplasia of
endothelial cells, vascular necrosis, extravasation
of erythrocytes, fibrin exudates, marked cerebral
oedema) in patients suffering ICH.18,25,26,29,32,33,39
From other work it is apparent that a combination of
hypertension and patent collateral vessels are required
to invoke experimental haemorrhagic infarction.50
There is some evidence to suggest that poorly
controlled pre-existing hypertension may also be of
relevance. Thus autopsy studies have shown that
longstanding hypertension is associated with the
development of intracerebral arteriolar microaneur-
ysms52,53 and the occurrence of small intracerebral
haemorrhages at the junction of cortical grey andwhite
matter. The increased susceptibility of hypertensives
Post-carotid Endarterectomy Cerebral Haemorrhage 117
Eur J Vasc Endovasc Surg Vol 28, August 2004
to ICH could be secondary to small vessel changes and
aneurysm rupture. This risk is likely to be further
increased by uncontrolled post-CEA hyperaemia in
patients with impaired cerebrovascular reserve and a
failure of normal autoregulation.
The possible mechanisms by which pre-existing
hypertension might increase the risk of ICH has been
examined in animal studies. Thus in an experimental
model of renal hypertension in monkeys persistent
segmental cerebral arteriolar spasm with stasis and
segmentation of blood was noted and brain histology
demonstrated arteriolonecrosis and cerebral fibrinoid
arteriolosclerosis.49 These changes were associated
with areas of ICH. Subsequently, Hardin, using an
identical animal model, was able to prevent haemor-
rhagic infarction, at the expense of ischaemic infarc-
tion, by administration of intravenous low molecular
weight dextran (LMWD) both before and after
induction of ischaemia. He concluded that vascular
stasis, sludging and anoxic changes affecting both the
vessel wall and surrounding parenchyma played a
major role in the pathogenesis of haemorrhagic
infarction.51 The protective effect of LMWD appeared
to be related to its indirect action of preventing further
anoxic damage to the vessel wall, and surrounding
parenchyma, perhaps by increasing microcirculatory
blood flow.
Finally, the effect of hypertension on cerebral blood
flow (CBF) has been assessed in both non-ischaemic
and ischaemic cerebral cortex. In the former CBF
remains relatively constant despite changes in blood
pressure whilst in ischaemic cortex CBF is directly
influenced by systemic blood pressure during periods
of both hypotension and normotension. Although
increased CBF is not a direct result of hypertension,
ischaemia impairs vascular reactivity with or without
maximal dilatation54 thus reducing vascular resist-
ance. This effect may be enhanced by intracellular
acidosis which further increases CBF in reperfused
ischaemic cortex.55
The association between peri-operative hyperten-
sion and ICH is not conclusive and of the studies
reviewed here in which sufficient information is
provided, 40/82 (49%) patients were hypertensive
whilst 41/82 (51%) had normal pre-operative blood
pressures, no history of post-CEA hypertension and
no autopsy changes consistent with malignant hyper-
tension.24,31,46 The incidence of hypertension in this
cohort is similar to that reported for patients in the
NASCET Study2 and this must raise doubts as to the
impact of hypertension on the development of post-
CEA ICH.
If there is a link between pre-operative hyperten-
sion and ICH this may simply reflect cerebral
hypoperfusion and an impaired cerebrovascular
reserve rather than being a risk factor in its own
right. Indeed, induced hypertension in monkeys
following occlusion of the middle cerebral artery
results in a pronounced increase in regional perfusion
pressure56 suggesting that hypertension may be
beneficial in reducing the risk of pre-operative stroke
due to hypoperfusion. Thus vigorous antihypertensive
therapy prior to surgery may be hazardous. Conver-
sely, hypertension might be considered as a marker of
increased risk for ICH in patients who have suffered a
previous cerebral infarction or who have an impaired
cerebrovascular reserve.
Intra-operative risk factors
Anaesthetic method
When CEA is performed under local or regional
anaesthesia a significant increase in systemic blood
pressure occurs after application of the carotid
clamps.57 This is associated with a spontaneous
recovery in the initial fall in parameters of cerebral
oxygenation. This presumably reflects simultaneous
intra-cerebral vasodilatation. If these changes persist
during reperfusion the risk of ICH might be increased.
Conversely, when general anaesthesia is used for
CEA cerebral oxygenation does not recover after
clamping the carotid vessels, perhaps increasing the
risk of ischaemic infarction. Review of detailed case
reports indicated that 41/86 patients had a general
anaesthetic and 3/86 local or regional anaesthesia. The
method of anaesthesia was not documented in 42
patients. In the 16 series reports reviewed the
proportions of local/regional anaesthesia compared
to general anaesthesia in patients who did not develop
ICH was not described.
Thus, at present, it is not possible to draw any
conclusions as to influence of general or local
anaesthesia upon the incidence of ICH. The ongoing
GALA Trial (an international randomised trial of
general versus local anaesthesia for CEA) should
provide further information on this issue.
Operative technique
Low cerebrovascular reserve with reduced flow from
the contralateral hemisphere should be associated
with a low mean stump pressure. Despite this, there is
no evidence that measurement of stump pressure
predicts at-risk patients, although the stump pressure
ratio (initial mean stump pressure/pre-occlusion
mean arterial pressure) may be of value.58 Similarly,
when a selective policy for shunt insertion is adopted
based upon an assessment (direct or indirect) of
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cerebral blood flow or function there is tentative
evidence that patients requiring a shunt may have a
higher risk of ICH. Thus, Jansen reported that a shunt
was deployed in 3/5 (60%) and 48/228 (21%) patients
who did or did not develop ICH. There is no reason to
believe that the shunt itself had any influence upon the
occurrence of ICH.
Review of the data from the 86 ICH patients in
whom more detailed information was available
indicated that 28 patients required a shunt and 15
did not. No data was available for the other 43
patients. In view of the missing data and a general
failure to report the reasons for shunt insertion
(routine or selective) no useful conclusions can be
drawn.
Finally, there is experimental evidence that impli-
cates a role for both peri-operative haemodynamic
ischaemia and embolisation in the pathogenesis of
some cases of ICH.42,59 Thus it is logical to suggest that
the strategies that minimise these risks (outlined
above), together with appropriate intra-operative
monitoring to detect their occurrence should be
employed. In respect of the latter awake neurological
testing during CEA under local/regional anaesthesia,
together with TCD monitoring of middle cerebral
artery blood flow (emboli detection) would seem the
most appropriate methods.
Intra-operative monitoring
Various techniques have been employed to identify
cerebral hypoperfusion after carotid cross clamping.
These depend on the measurement of haemodynamic
parameters (stump pressure, middle cerebral artery
velocity [MCAV]), parameters of cerebral oxygenation
(near infrared spectroscopy, jugular venous blood O2
saturation) or cerebral function (EEG, somatosensory
evoked potentials, awake neurological testing). Their
main function is to identify, with varying sensitivity
and specificity, those patients who require a shunt. As
discussed earlier a low stump pressure does not have
any predictive value for the development of ICH.
Similarly, the benefit of EEG in this role has also been
examined with negative results.21,22,25,26,37 The value
of other monitoring modalities has not been critically
assessed.
There is some evidence that close monitoring of
peri-operative blood pressure changes may be helpful.
Thus, of 20 patients with ICH where intraoperative
blood pressure was documented 14 showed a rise of
.40 mmHg in systolic blood pressure above pre-
operative levels, one a rise of ,40 mmHg, and five no
change.19,20,25,31,33,37,39
Several authors have also shown that post-CEA
changes in cerebral blood flow or MCAV predict
patients at risk of both hyperperfusion and ICH. Thus,
Sundt et al. reported that cerebral blood flow may
increase by as much as 200% in patients who
subsequently developed neurological complications.46
More recently, Henderson et al. showed that .60% of
patients who suffered an ICH had a.100% increase in
cerebral blood flow post-operatively.30
Other authors have suggested that TCD monitoring
has a role in the detection and evaluation of post-CEA
hyperperfusion.23,48 Similarly, Jansen et al., using a
combination of a$175% increase in peak MCAVand a
pulsatility index increase $100% reported that the
positive predictive value, negative predictive value,
sensitivity and specificity for developing ICH were
100, 99, 80 and 100%, respectively.13 These data appear
highly promising and thus measures that might
reverse these changes could have a major role in
reducing the incidence of post-CEA ICH.
Anticoagulation
Administration of intra- and post-operative antiplate-
let agents and anticoagulants have been implicated in
the pathogenesis of ICH by several authors19,27,30 and
Meyer and Denny-Brown showed that anticoagulation
promoted ICH in an experimental model.41 However,
the majority of endarterectomies are performed using
both intra-operative heparin and post-operative anti-
platelet therapy making it difficult to substantiate the
role of these agents in promoting ICH. In this respect
Poisik et al. failed to show a link between fixed-dose
heparin therapy during CEA and ICH.60
Further, the Mayo Clinic asymptomatic carotid
endarterectomy trial was stopped early due to a
higher rate of myocardial events in patients random-
ised to receive no antiplatelet therapy.61 Similarly,
anticoagulants prolong patient survival post-CEA,
probably by reducing coronary events.62 In this latter
study, there was no difference in the frequency of
cerebral events between patients receiving anticoagu-
lants/antiplatelet drugs and those who did not
although the precise nature of the neurological events
was not specified.
In summary, although these drugs may increase
haemorrhage once it has started they almost certainly
do not initiate ICH. Further, it appears that the
increased risk of morbidity without their use out-
weighs any potential risk.
Post-operative risk factors
Hypertension
An abrupt elevation in blood pressure frequently
occurs in association with the onset of neurological
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symptoms in patients with ICH and often follows a
period of normotension. It is difficult know whether
this is important in the pathogenesis of ICH or if it is a
normal response to a sudden rise in intracranial
pressure. Nevertheless, it is advisable to institute
aggressive anti-hypertensive therapy if such a rise
occurs.
Discussion
From this review a number of factors appear to be
associated with an increased risk of ICH following
CEA. These are:
1. Pre-operative hypertension.
2. Recent ipsilateral non-haemorrhagic stroke.
3. Previous ischaemic cerebral infarction.
4. .90% stenosis of the ICA for operation.
5. Severe bilateral disease or a contralateral ICA
occlusion.
6. Impaired cerebrovascular reserve.
7. Haemodynamic or embolic intra-operative
ischaemia.
8. $175% increase in peak MCAV on transcranial
Doppler assessment of ipsilateral middle cerebral
artery flow velocities and/or a pulsatility index
$100%.
9. .200% increase in cerebral blood flow.
10. Post-operative hypertension.
Unfortunately, it is not possible to determine the
overall statistical significance of these potential risk
factors from the studies retrieved during our literature
review. This would require data on the incidence of
these risk factors not only in patients developing ICH
but also those suffering an ischaemic stroke and those
who did not develop a neurological complication. This
information is not available in the majority of
publications.
Potential interventions for patients believed to be at high
risk for ICH
Although active intervention for pre-operative hyper-
tension could be potentially harmful, particularly in
patients with a critical stenosis it would seem sensible
to intervene in patients developing post-operative
hypertension. When this is required antihypertensives
causing vasodilatation should be avoided and rapid
control of hypertension achieved by intravenous
administration of a b-blocker such as labetolol.
Whilst there are no direct interventions that
diminish the risk of ICH associated with previous
cerebral infarction, the timing of surgery following a
recent stroke requires consideration. Cerebral auto-
regulatory responses to CO2 recover 3–4 weeks after
cerebral infarction yet disautoregulation following
induced hypertension may continue for up to 2
months after a stroke.63 Although initial reports
suggested that the risk of ICH following CEA in
patients with acute stroke was as high as 60%64 later
studies indicated that the risk in patients with non-
disabling stroke was no different whether CEA is
performed within 30 days of symptoms or delayed
beyond this time.65,66 Conversely, patients with evol-
ving neurological signs67 or associated comorbidity
(ASA III or IV)68 have an increased risk when CEA is
performed within 3 weeks. A recent review has
suggested that surgery might be expedited in patients
who make a rapid recovery from their stroke and who
have a relatively small infarct on CTwhereas in those
with larger infarcts and a significant residual neuro-
logical deficit surgery should be deferred for 6–8
weeks.69
In patients with severe ICA disease the risk of ICH
appears to be associated with impaired cerebrovascu-
lar reserve. This can be assessed bymeasuring changes
in MCAV before and after acetazolamide or CO2 using
TCD. If it is not practical to determine this in all
patients prior to CEA then those at risk are likely to be
patients with a$90% ICA stenosis, a.70% stenosis in
association with a contralateral occlusion, or bilateral
stenoses of .80%.
Although there is no data to indicate the appro-
priate management for patients with an impaired
reserve following reperfusion it would be logical to
monitor both the MCAV and pulsatility index. If these
parameters exceed the limits indicated above then
steps should be taken to normalise them. Logically,
promotion of intra-cerebral vasoconstriction should
reverse the abnormal flow associated with hyperper-
fusion. Methods by which this might be achieved
include a period of hypocarbic ventilation if the
MCAV or pulsatility index are significantly elevated
at the end of surgery or administration of drugs such
as b-blockers although the role of the latter is
conjectural. These measures should be continued
until the haemodynamic abnormalities stabilise
below the apparently ‘critical’ levels described earlier.
The 5-HT 1B/1D receptor agonist sumatriptan attenu-
ates experimentally induced cerebral hyperperfusion
in both rat70 and baboon71 models, whilst having no
effect on blood flow at normal flow volumes. In
patients with migraine it causes vasoconstriction of the
internal carotid and middle cerebral arteries72,73 with-
out inducing changes in systemic cardiovascular
parameters. Thus sumatriptan may reduce the cer-
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ebral hyperperfusion preceding ICH. None of these
strategies have been critically assessed following CEA.
Given the relatively low incidence of ICH, initial
studies should probably assess the physiological effect
of these manoeuvres in a cohort of CEA patients.
Although it would be attractive to subsequently
perform a randomised study to investigate the role
of the most promising methods the relatively low
incidence of ICH means such an investigation would
require a large multi-centre trial.
Finally, discharge should be delayed for high risk
patients until the MCAV and pulsatility index, which
should be measured on a daily basis, have started to
fall towards normal levels.
Following discharge patients should be advised to
return to hospital immediately if they develop a severe
headache within the first month of surgery whereupon
a TCD study and cerebral CT scan should be
performed.
The suggested protocols for reducing the risk of
ICH are summarised in Fig. 1.
Summary
ICH is the most serious manifestation of post-CEA
cerebral hyperperfusion, the latter being promoted by
an impaired cerebrovascular reserve with maximal
dilatation of intracerebral vessels and failure of
cerebral autoregulation. Pre-operative screening and
post-endarterectomy monitoring of high risk patients
might identify those who would benefit from manipu-
lation of the haemodynamic events that appear to
promote ICH. Further research is required to confirm
the hypotheses outlined in this review and to
formulate appropriate pharmacological protocols to
reduce the risk of an adverse neurological event. Such
manoeuvres might play an important role in reducing
the morbidity and mortality of surgery given the
implementation of other strategies that make carotid
endarterectomy safer.
Finally, the problems of hyperperfusion and ICH
will be equally important for patients treated by
endovascular methods for carotid disease.
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